Feedback / Questions
ADS051 - Adiso Therap
https://www.prnewswire.com/news-releases/adiso-therapeutics-announces-positive-topline-data-from-phase-1b-study-of-ads051-for-the-treatment-of-moderate-to-severe-ulcerative-colitis-301963581.html
Oct 22, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next